In 2015, a few weeks into my first job working with patients at Mass General Hospital, I met a mother who lost her adult son to cancer and now spent her weeks...
Putting Rare Cancers on the Map: Reflections from ASCO 2026
read more
News
$1 Million and Counting: How Our 2026 Boston Marathon Team Made History
Monday, April 20, was a spectacular day in Boston as 13 members of Team TargetCancer Foundation 2026 triumphantly crossed the finish line of the 130th Boston...
2025 in Review: A Year of Strength and Growth
TargetCancer Foundation's (TCF) supporters and partners came together in meaningful ways in 2025, illustrating the strength and power of the rare cancer...
We Can’t Stop Now — Why We Must Raise Our Voices In Support of Rare Cancer Research
This perspective was written by Kristen Palma, President, TargetCancer Foundation In my life I have had the experience of being a caregiver to a loved one who...
TCF Announces Paying With Our Lives: Save Rare Cancer Research Advocacy Campaign
Speak Out to Save Rare Cancer Research! There’s no such thing as a “good” cancer diagnosis. Hearing the words “you have cancer” unleashes fear, uncertainty,...
Translating Loss into Discovery: Paul’s Legacy
This reflection was written by Kristen Palma, President, TargetCancer FoundationThis is a story about possibility, even when confronted with an impossible...
A Promise Fulfilled: 15 Years After Paul Poth’s Vision, a New Era in Cholangiocarcinoma Research Begins
A founding goal of TCF is realized as researchers identify potential drug targets and uncover novel disease subtypes through in-depth genetic and cellular...
TCF Statement Regarding Recent Executive Actions
If you have questions or would like to be involved in advocacy efforts, please contact Kristen at: [email protected]
2024: A Milestone Year in Review
Looking back at the biggest year in TCF history As we near the end of 2024, we are very proud to look back on a 15th anniversary year that has seen...
Introducing TCF’s 2025 Boston Marathon team!
As we enter the season of thankfulness and giving, it is with gratitude and excitement that we introduce the 12 incredible individuals who have been selected...
Patients and Practitioners as Partners: 2024 Rare Cancer Day Webinar
On September 30, TargetCancer Foundation was pleased to host a Lunch and Learn Webinar in honor of Rare Cancer Day. Dr. Mina Nikanjam, an oncologist at...
Making Rare Cancer Day A Reality
This reflection was written by: Jim Palma, Chief Executive Officer Like many people in the rare cancer advocacy world, I entered my own advocacy work...
Connecting the Dots: Two Months at TCF
This reflection was written by: Hetal Vig, MS, MGC, Director of Research and Clinical Engagement In the words of Steve Jobs, “You can’t connect the dots...
Remembering at 15 years
Dear Friends, This past spring, TCF celebrated 15 years of amazing achievement in rare cancer research. We have so much to be proud of, and I am. But today is...
Welcome, Hetal!
A Message from TargetCancer Foundation President Kristen Palma: When TCF was founded in 2009, we started around the kitchen table. It was Paul, myself and my...